Atea Pharmaceuticals shares owned by Jacobs Levy Equity Management
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Jacobs Levy Equity Management
from 13F filings
Historical chart of Jacobs Levy Equity Management investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by Jacobs Levy Equity Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by Jacobs Levy Equity Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.7M | 551k | 3.05 |
| 2023-09-30 | $1.7M | 553k | 3.00 |
| 2023-06-30 | $2.1M | 565k | 3.74 |
| 2023-03-31 | $2.1M | 632k | 3.35 |
| 2022-12-31 | $2.4M | 499k | 4.81 |
| 2022-09-30 | $2.2M | 381k | 5.69 |
| 2022-06-30 | $3.1M | 432k | 7.10 |
| 2022-03-31 | $1.1M | 154k | 7.22 |
More positions owned by Jacobs Levy Equity Management
View all positions for Jacobs Levy Equity Management